Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Obeticholic Acid for Prevention in Barrett?s Esophagus
Study Type: Treatment
Phase: N/A
NCTID: NCT04939051
Principal Investigator:
Reza Hejazi
A Phase I/II Trial of the prebiotic galacto-oligosaccharide to prevent Acute GVHD
Study Type: Prevention
Phase: I/II
NCTID: NCT04373057
Principal Investigator:
Anthony Sung
INT23-14-01, Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction RENAISSANCE: A Phase II Single Arm Trial
Study Type: Prevention
Phase: II
NCTID: NCT06184750
Principal Investigator:
Carol Fabian
Molecular Genetics Studies of Cancer Patients and Their Relatives
Study Type: Other
Phase: N/A
NCTID: NCT04185935
Principal Investigator:
Jeffrey Weitzel
The Role of Androgen Deprivation Therapy In CArdiovascular Disease ? A Longitudinal Prostate Cancer Study RADICAL PC1 and A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients RADICAL PC2
Study Type: Prevention
Phase: IV
NCTID: NCT03127631
Principal Investigator:
Charles Porter
Phase IIA Trial of Acolbifene 20 mg vs Low Dose Tamoxifen 5 mg in Pre-menopausal Women at High Risk for Development of Breast Cancer
Study Type: Prevention
Phase: II
NCTID: NCT05941520
Principal Investigator:
Carol Fabian
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk
Study Type: Prevention
Phase: N/A
NCTID: NCT04251052
Principal Investigator:
Andrea Jewell
Ice Compress: Randomized Trial of Limb Cryocompression versus continuous Compression versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy
Study Type: Prevention
Phase: N/A
NCTID: NCT05642611
Principal Investigator:
Lauren Nye
4th Generation e-cigarettes in African American Smokers: Reducing Harm and Quitting Combustible Cigarettes in Dual Users
Study Type: Prevention
Phase: II/III
NCTID: NCT05703672
Principal Investigator:
Nicole Nollen
Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation
Study Type: Prevention
Phase: III
NCTID: NCT05711667
Principal Investigator:
Ibrahim Ahmed